Medviso AB develops 3D segmentation software for patient-specific 3D anatomical models, surgical planning models and implants. Our focus is to empower physicians and engineers with easy-to-use software for generation of high-quality models of all anatomical structures.Continue reading “3D printed patient-specific cranioplasty moulds in clinical routine”
A presentation by Alessandro Ricci, 3DIFIC.
We’ll cover the application of segmentation of liver cancers for diagnosys and support to treatment.Continue reading “Multi-timing segmentation for liver cancer treatment”
presentation by Sandra Van Vlierberghe, Ghent University.
Biofabrication is a specific area within the field of tissue engineering which takes advantage of rapid manufacturing (RM) techniques to generate 3D structures which mimic the natural extracellular matrix (ECM). A popular material in this respect is gelatin, as it is a cost-effective collagen derivative, which is the major constituent of the natural ECM.Continue reading “Photo-crosslinkable polymer platform to serve medical applications”
We welcome 3DIFIC as Gold Partner of Online 3D Medtech Printing Conference (4 CME credits), 2 February 2021, 14:00 – 18:00 CET REGISTER HERE
3DIFIC is an innovative startup, under the Italian Law, and has been spinoffed by the School of Medicine of the University of Perugia (Perugia, Italy). In the last years 3DIFIC has developed a number of cases in surgery and in dental practice. Now 3DIFIC accounts for a number of cases with either high complexity or high volumes potential, thanks to an extraordinary team that was put together in the years.Continue reading “3DIFIC is Gold Partner of Online 3D Medtech Printing Conference”
Cathy Ye, Associate Professor, Director of Oxford Centre for Tissue Engineering and Bioprocessing, University of Oxford, will moderate the 2021 edition of the conference.
Professor Hua Ye, University of Oxford
Dr. Ye is an Associate Professor in Engineering Science in the Institute of Biomedical Engineering at University of Oxford. Dr. Ye holds a degree in Chemical Engineering from Dalian University of Technology (1998), China and a Ph.D. in Engineering from University of Oxford (2005).
presentation by Philip Smith, CEO, 4D Biomaterials
4D Biomaterials is introducing a new class of 3D printing resin-inks for medical applications. In this first public presentation of the company’s technology, we will outline the unique properties of the materials including their biocompatibility, degradation/resorption behaviour and physical characteristics.Continue reading “4D Biomaterials – so what’s new?”